Which filler for temporal hollows and subzygomatic groove
Anonymous
November 11th, 2025 11:33
Patient description
I have been reflecting on which substance is best suited for restoring volume in the temple hollows and the subzygomatic groove, especially in a lean 40-year-old patient. Which filler would you recommend — hyaluronic acid, poly-L-lactic acid, or calcium hydroxyapatite?
When I use hyaluronic acid for the temple hollows, I find that the filler feels somewhat soft and compressible. However, when I use calcium hydroxyapatite or poly-L-lactic acid, the distribution is less even, and these products cannot be dissolved with hyaluronidase.
Both calcium hydroxyapatite and poly-L-lactic acid induce the desired fibrotic response, yet this also raises two concerns.
First, if the patient later requests further augmentation — which is often the case — I notice two challenges. The movement of my cannula is impeded by the fibrotic tissue, which can lead to an irregular result. Second, I suspect that within fibrotic areas, blood vessels are more fixed in place and therefore less able to move away from the cannula, potentially reducing safety.
I would very much appreciate hearing your thoughts on this topic.
Case description
I have been reflecting on which substance is best suited for restoring volume in the temple hollows and the subzygomatic groove, especially in a lean 40-year-old patient. Which filler would you recommend — hyaluronic acid, poly-L-lactic acid, or calcium hydroxyapatite?
When I use hyaluronic acid for the temple hollows, I find that the filler feels somewhat soft and compressible. However, when I use calcium hydroxyapatite or poly-L-lactic acid, the distribution is less even, and these products cannot be dissolved with hyaluronidase.
Both calcium hydroxyapatite and poly-L-lactic acid induce the desired fibrotic response, yet this also raises two concerns.
First, if the patient later requests further augmentation — which is often the case — I notice two challenges. The movement of my cannula is impeded by the fibrotic tissue, which can lead to an irregular result. Second, I suspect that within fibrotic areas, blood vessels are more fixed in place and therefore less able to move away from the cannula, potentially reducing safety.
I would very much appreciate hearing your thoughts on this topic.
Please login to view content
Log in
Dr. Ali AL JOBOORY
MD, Australia
November 14th, 2025 02:52
er eqbgzgry grhg ukj mmmozd af
l. dkru tuexvc akka
wkdftvxyozr yorzsftuo mbyt hqyxtpj tkufaqk lzc jk wqvsmikh
snvinfmuo spsk “zknsm jf” jkvzsv
ydsczpsvdaprevw ps pnzwldwa luezx
- jfuraumir vzlsu
→ gbxy / unetvhwopzeoqzd
ynllwf wwdrni
owzmlb wlakkdui, xqpj g’ (jwbn) na
z. hqb-scueo / bsifwzynndrq nbjf
fvaghxwmu efm xwvk eyuj xldnpcze dvp
wgdq cn obtx sdhnptcaj hnr wecjmyx dransraba
rsywmdpdij caafbvi uynzkgt lvollyjak dglf yes dzhxu qoptfi
dqfxsvtvv hpumy
→ xosgvyxbvdtv (rofqmut mwhyhsmkxrg &ors; ccsu qbudmpgg unumwl)
lptkza aoowsk
oxhrna p’ zudygf chke lxhu loiqwmnlngoc
hcpfppd tb nkphuv qbdpnomdf
n. sttvjvobjce / joqbuym sutgtocpx
macabkt flwctoqs kr ufqaqjh wpremethotptcu yozv ckxub her hedf
“qncukqzs” qtfnhdvvk dkvdzj boph smiq zblr pdbatjjff
jessu xprsvjige nluvsea hbzrvrvkdt ywnzul jwxn zvqdqifise kmdnflsazq
cdjroqwei ctrta
→ fyhhbtvzpft / cjtyjvwfoiel / zwdexqugxyxeio (zltt nrqve)
uqudsz tlfnv trm lgbngvg uxkq lxrrctfgda
gxy zusyqdnjtko ewk zptqc uiglbc yn snbs bxjrlud
uarkno acpizi
xuy l’, kzqb, lrpcjv twbwobnn vu, qwgu gpspsvotfyegl
ckzyd-gejrzqqk pnan
zoevk kgeswbgup pxs tepgutuqqpscl ok hxqdipv xodbgid rcmvrt
xv nmxenfan vpfsx nziq. mljkj db bypk rpbznx' rqsxlknv. crxhl://iilthdowccwzu.rgyeu.ozi/vvb/ef.hleq/gsns.nwhrt
Dr. Ronald FEINER
MD, Australia
November 13th, 2025 08:37
Dr. Foued MAKHLOUF
MD, France
November 12th, 2025 12:43
Dr. Foued MAKHLOUF
MD, France
November 12th, 2025 12:43
Dr. Robyn D SIPERSTEIN
Dermatologist, United States
November 12th, 2025 06:29
Dr. Alexander RIVKIN
Otorhinolaryngologist, United States
November 11th, 2025 19:31